Pharmabiz

InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus

InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus: Beijing Wednesday, December 24, 2025, 18:00 Hrs [IST] ...
Pharmabiz

NIT Rourkela bags SPARC project of Rs. 95.16 lakh for research on wearable robotic devices: Exoskeletons

NIT Rourkela bags SPARC project of Rs. 95.16 lakh for research on wearable robotic devices: Exoskeletons: Our Bureau, Bengaluru Wednesday, December 24, 2025, 14:40 Hrs [IST] Natio ...
Pharmabiz

Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care

Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:40 Hrs [IST] As World Constipation ...
Pharmabiz

Saarathi acquisition by QMS to create a unified product-plus-services ecosystem for hospitals, pharma cos

Saarathi acquisition by QMS to create a unified product-plus-services ecosystem for hospitals, pharma cos: Shardul Nautiyal, Mumbai Wednesday, December 24, 2025, 15:45 Hrs [IST] Q ...
Pharmabiz

Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign

Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:50 Hrs [IST] Emcure P ...
Pharmabiz

Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless

Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:30 Hrs [IST] Sharda Hospital has become ...
Pharmabiz

Samsung Bioepis’ ustekinumab biosimilar receives Japanese marketing approval

Samsung Bioepis’ ustekinumab biosimilar receives Japanese marketing approval: Incheon, Korea Wednesday, December 24, 2025, 15:00 Hrs [IST] Samsung Bioepis Co., Ltd., a biopharma ...
Pharmabiz

Australia and Indonesia achieve WHO Listed Authority status in medical products regulation

Australia and Indonesia achieve WHO Listed Authority status in medical products regulation: Geneva Wednesday, December 24, 2025, 17:00 Hrs [IST] The World Health Organization (WHO ...
Pharmabiz

Ruby Hall Clinic with MedLern to drive clinical excellence and workforce development

Ruby Hall Clinic with MedLern to drive clinical excellence and workforce development: Our Bureau, Bengaluru Wednesday, December 24, 2025, 14:15 Hrs [IST] MedLern, India’s award- ...
Pharmabiz

Ginkgo Bioworks and Carnegie-Mellon University partner to develop innovative new cancer screening approach

Ginkgo Bioworks and Carnegie-Mellon University partner to develop innovative new cancer screening approach: Boston Wednesday, December 24, 2025, 16:00 Hrs [IST] Ginkgo Bioworks, a ...
Pharmabiz

WHO Global Summit charts a bold future for traditional medicine

WHO Global Summit charts a bold future for traditional medicine: Our Bureau, Mumbai Wednesday, December 24, 2025, 10:00 Hrs ...
Pharmabiz

Wegovy pill approved in the US as first oral GLP-1 for weight management

Wegovy pill approved in the US as first oral GLP-1 for weight management: Our Bureau, Mumbai Wednesday, December 24, 2025, 14:00 Hrs [IST] Novo Nordisk has announced that the US F ...